Nishant Agrawal to Mice
This is a "connection" page, showing publications Nishant Agrawal has written about Mice.
Connection Strength
0.125
-
PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands. J Exp Clin Cancer Res. 2025 Jan 11; 44(1):11.
Score: 0.022
-
Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc Natl Acad Sci U S A. 2004 Oct 19; 101(42):15172-7.
Score: 0.021
-
A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors. Neuro Oncol. 2024 Oct 03; 26(10):1895-1911.
Score: 0.021
-
Generation of neoantigen-specific T cells for adoptive cell transfer for treating head and neck squamous cell carcinoma. Oncoimmunology. 2021 05 25; 10(1):1929726.
Score: 0.017
-
GOSPEL: a neuroprotective protein that binds to GAPDH upon S-nitrosylation. Neuron. 2009 Jul 16; 63(1):81-91.
Score: 0.007
-
Pharmacologic and toxicologic evaluation of C. novyi-NT spores. Toxicol Sci. 2005 Dec; 88(2):562-75.
Score: 0.006
-
p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron. 2005 Jul 07; 47(1):29-41.
Score: 0.006
-
S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol. 2005 Jul; 7(7):665-74.
Score: 0.006
-
Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil. Proc Natl Acad Sci U S A. 2005 Jan 25; 102(4):1145-50.
Score: 0.005
-
Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7R. Cancer Res. 2004 Dec 01; 64(23):8507-11.
Score: 0.005
-
Targeting vascular and avascular compartments of tumors with C. novyi-NT and anti-microtubule agents. Cancer Biol Ther. 2004 Mar; 3(3):326-37.
Score: 0.005
-
Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria. Proc Natl Acad Sci U S A. 2003 Dec 09; 100(25):15083-8.
Score: 0.005